Skim Milk Powder
販売終了
|
|
Skim Milk Powder with Melamine - Level A
販売終了
|
|
Skim Milk Powder with Melamine - Level C
販売終了
|
|
Skim Milk Powder with Melamine - Level D
販売終了
|
|
Skim Milk Powder with Melamine - Level E
販売終了
|
|
Saccharin (200 mg)
|
|
Saccharin Calcium (150 mg)
|
|
Saccharin Sodium (200 mg)
|
|
Safflower Oil (1 g)
|
|
Salicylamide (200 mg)
|
|
サリチル酸
|
|
Salicylic Acid Related Compound A (100 mg) (4-hydroxybenzoic acid)
|
|
Salicylic Acid Related Compound B (100 mg) (4-hydroxyisophthalic acid)
|
|
Salidroside (25 mg) (2-(4-Hydroxyphenyl)ethyl-Beta-D-glucopyranoside)
|
|
Salmeterol Resolution Check (15 mg)
|
|
Salmeterol System Suitability (15 mg) (Mixture containing salmeterol xinafoate, salmeterol-N-alkyl and salmeterol related compound H)
|
|
Salmeterol Xinafoate (150 mg)
|
|
Salmeterol Related Compound A (20 mg) (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol)
|
|
Salmeterol Related Compound B (3 x 1.3 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-
|
|
Salmeterol Related Compound H (30 mg) (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate)
|
|
Salsalate (150 mg)
|
|
Salvianolic Acid B (25 mg)
|
|
Saquinavir Mesylate (200 mg)
|
|
Saquinavir Related Compound A (25 mg) (N-tert-butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-D-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide)
|
|
Schisandrin (15 mg)
|
|
Schisandra chinensis Fruit Dry Extract (1 g)
|
|
Scopolamine Hydrobromide (500 mg)
|
|
Scopoletin (20 mg)
|
|
Secoxyloganin (50 mg) ([(2S,3R,4S)-2-(beta-D-Glucopyranosyloxy)-5-(methoxycarbonyl)-3-vinyl-3,4-dihydro-2H-pyran-4-yl]acetic acid)
|
|
Selamectin (350 mg)
|
|
Selegiline Related Compound D (15 mg) ((R)-N-(1-Phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride)
|
|
Selenomethionine (100 mg)
|
|
Sennosides (500 mg)
|
|
Sennoside A (20 mg) ((9R,9'R)-5,5'-Bis(beta-d-glucopyranosyloxy)-4,4'-dihydroxy-10,10'-dioxo-9,9',10,10'-tetrahydro-9,9'-bianthracene-2,2'-dicarboxylic acid)
|
|
Sennoside B (20 mg)
|
|
Sesame Oil (1 g)
|
|
Sesame Oil Related Compound A (12 mg/vial; 2 vials) (1,2-dilinoleoyl-3-oleoyl-rac-glycerol) (OLL)
|
|
Sesame Oil Related Compound B (12 mg x 2 vials) ((1,2-Dilinoleoyl-3-palmitoyl-rac-glycerol) (PLL))
|
|
L-Serine (200 mg)
|
|
Sertraline Hydrochloride Racemic Mixture (30 mg) ((1RS,4RS)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride)
|
|
Sertraline Hydrochloride Related Compound A (25 mg) ((1RS,4SR)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride)
|
|
Sertraline Hydrochloride (100 mg)
|
|
Sevoflurane (1 mL)
|
|
Sevoflurane Related Compound A (0.2 mL) (1,1,1,3,3-Pentafluoroisopropenyl fluoromethyl ether)
|
|
Sildenafil Citrate (100 mg)
|
|
Sevoflurane Related Compound B (0.2 mL) (1,1,1,3,3,3-hexafluoro-2-methoxy-propane)
|
|
Sevoflurane Related Compound C (0.2 mL) (1,1,1,3,3,3-hexafluoro-2-propanol)
|
|
Silver Sulfadiazine (200 mg)
|
|
Silybin (50 mg)
|
|
Silydianin (30 mg)
|
|
Simethicone (50 g)
|
|
Sildenafil Related Compound A (10 mg) (1-{[3-(6,7-Dihydro-1-methyl-7-oxo-3-isobutyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl}-4-methylpiperazine)
|
|
Simvastatin (200 mg)
|
|
Sisomicin Sulfate (500 mg)
|
|
Sibutramine Related Compound A (20 mg) (N-{1-[1-(2-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine hydrochloride)
|
|
Sibutramine Related Compound B (20 mg) (N-{1-[1-(3-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine hydrochloride)
|
|
Sibutramine Related Compound C (20 mg) (N-{1-[1-(4-chlorophenyl)cyclobutyl]pentyl}-N,N-dimethylamine hydrochloride)
|
|
Sibutramine Related Compound D (20 mg) (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N-methylamine hydrochloride)
|
|
Sitagliptin Phosphate (200 mg)
|
|
Sitagliptin System Suitability Mixture (20 mg) (Sitagliptin Phosphate containing about 0.2% of S-enantiomer)
|
|
Sodium Acetate (1 g)
|
|
Sodium Acetate Trihydrate (1 g)
|
|
Sodium Ascorbate (200 mg)
|
|
Sodium Benzoate (1 g)
|
|
Sodium Bromide (1 g)
|
|
Sodium Butyrate (25 mg)
|
|
Sodium Bicarbonate (3 g)
|
|
Sodium Decanoyl Sarcosinate (30 mg) (Sodium N-decanoyl-N-methylglycinate)
|
|
Sodium Carbonate Anhydrous (1 g)
|
|
Sodium Chloride (1 g)
|
|
Sodium Citrate (1 g)
|
|
Sodium Cyclamate (200 mg)
|
|
Sodium D,L-Malate (50 mg) (PLANNED TO BE DISCONTINUED)
販売終了
|
|
Sodium D-Pantoate (100 mg)
|
|
Sodium Hyaluronate for IR Identification (250 mg)
|
|
Sodium Iron EDTA (200 mg)
|
|
Sodium Lactate (200 mg)
|
|
Sodium Lauryl Sulfate (1 g)
|
|
Sodium Myristoyl Sarcosinate (30 mg) (Sodium N-methyl-N-tetradecanoylglycinate)
|
|
Sodium Metabisulfite (2 X 500 mg)
|
|
モリブデン酸ナトリウム二水和物
販売終了
|
|
Sodium Nitrite (1 g)
|
|
Sodium Nitroprusside (500 mg)
|
|
Sodium Phenylbutyrate (200 mg)
|
|
Sodium Picosulfate (100 mg)
|
|
Sodium Picosulfate Related Compound A (20 mg) (4-[(Pyridin-2-yl)(4-hydroxyphenyl)methyl]phenyl sodium sulfate)
|
|
Sodium Propionate (200 mg)
|
|
Sodium Starch Glycolate Type A (400 mg)
|
|
Sodium Starch Glycolate Type B (400 mg)
|
|
Sodium Stearyl Fumarate (200 mg)
|
|
Sodium Sulfate Anhydrous (1 g)
|
|
Sodium Tartrate Dihydrate (500 mg/vial; 4 vials)
|
|
Sodium Thiosulfate (1 g)
|
|
Sodium Trifluoroacetate (500 mg)
|
|
Solifenacin Succinate (100 mg)
|
|
Solifenacin Identification Mixture A (15 mg)
|
|
Sorbic Acid (1 g)
|
|
1,4-Sorbitan (300 mg)
|
|
Sorbitol (125 mg)
|
|
Sotalol Hydrochloride (300 mg)
|
|
Sotalol Related Compound A (50 mg) (N-[4-[[(1-Methylethyl)amino]acetyl]phenyl]methanesulfonamide monohydrochloride)
|
|
Sotalol Related Compound B (50 mg) (N-(4-Formylphenyl)methanesulfonamide)
|
|
Sotalol Related Compound C (50 mg) (N-{4-[2-(Isopropylamino)ethyl]phenyl}methanesulfonamide hydrochloride)
|
|
Soybean Oil (1 g)
|
|
Spectinomycin Hydrochloride (200 mg)
|
|
Spironolactone (125 mg)
|
|
Spironolactone Related Compound A (100 mg) ((2'R)-3',4'-Dihydro-5'H-spiro[androst-4,6-diene-17,2'-furan]-3,5'-dione)
|
|
Spironolactone Related Compound B (30 mg) ((2'R)-7alpha-(Acetylthio)-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione)
|
|
Spironolactone Related Compound C (30 mg) ((2'R)-3',4'-Dihydro-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione)
|
|
Spironolactone Related Compound D (30 mg) ((2'R)-7alpha-(Acetyldisulfanyl)-3',4'-dihydro-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione)
|
|
Spironolactone Epimer Mixture (30 mg) (7-Epispironolactone approximately 56% and Spironolactone approximately 39% mixture)
|
|
Spironolactone Related Compound I (30 mg) (S-[17alpha-(Ethoxymethyl)-17-hydroxy-3-oxoandrost-4-en-7alpha-yl]ethanethioate)
|
|
Spirulina (2 x 100 mg)
|
|
Squalane (500 mg)
|
|
Stavudine (250 mg)
|
|
Stavudine System Suitability Mixture (10 mg)
|
|
Stearic Acid (500 mg)
|
|
Stearoyl Polyoxylglycerides (100 mg)
|
|
Stearyl Alcohol (125 mg)
|
|
Steviol Glycosides System Suitability (50 mg)
|
|
Stevioside (30 mg)
|
|
Streptomycin Sulfate (200 mg)
|
|
Succinic Acid (300 mg)
|
|
Succinylcholine Chloride (500 mg)
|
|
Succinylmonocholine Chloride (50 mg)
|
|
Sucrose Octaacetate (500 mg)
|
|
Sucralose (400 mg)
|
|
スクロース
販売終了
|
|
Sucromalt (200 mg)
|
|
Sulbactam (250 mg) (COLD SHIPMENT REQUIRED)
|
|
Sulconazole Nitrate (200 mg)
|
|
Sulconazole Related Compound A (15 mg) (1-[2-(4-Chlorobenzyl)sulfinyl-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate)
|
|
スルファベンズアミド
販売終了
|
|
Sulbactam Related Compound A (15 mg) ((2S)-2-Amino-3-methyl-3-sulfinobutanoic acid)
|
|
Sulbactam Related Compound D (15 mg) (Potassium (2S,5R,6R)-6-bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate)
|
|
Sulbactam Related Compound E (15 mg) ((2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide)
|
|
Sulbactam Related Compound F (15 mg) ((2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid)
|
|
スルファセタミド
販売終了
|
|
Sulfacetamide Sodium (500 mg)
|
|
Sulfachlorpyridazine (200 mg)
|
|
Sulfadiazine (200 mg)
|
|
Sulfadimethoxine (200 mg)
|
|
Sulfadoxine (200 mg)
|
|
Sulfamerazine (500 mg)
|
|
Sulfamethazine (1 g)
|
|
Sulfamethazine Related Compound A (4-Amino-N-carbamimidoylbenzenesulfonamide-, monohydrate)
販売終了
|
|
Sulfamethazine Related Compound B (Mixture containing about 49% of 4-Amino-2-chloro-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide and about 48% of 4-Amino-3-chloro-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide)
販売終了
|
|
Sulfamethizole (200 mg)
|
|
Sulfamethoxazole (200 mg)
|
|
Sulfamethoxazole N4-Glucoside (25 mg) (4-(beta-D-glucopyranosylamino)-N-(5-methyl-3-isoxazolyl)-benzenesulfonamide)
|
|
Sulfamethoxazole Related Compound A (15 mg) (N-{4-[N-(5-methylisoxazol-3-yl)sulfamoyl]phenyl}acetamide)
|
|
Sulfamethoxazole Related Compound B (15 mg) (4-amino-N-{4-[N-(5-methylisoxazol-3-yl)sulfamoyl]phenyl}benzenesulfonamide)
|
|
Sulfamethoxazole Related Compound C (15 mg) (5-methylisoxazol-3-amine)
|
|
Sulfamethoxazole Related Compound F (15 mg) (4-amino-N-(3-methylisoxazol-5-yl)benzenesulfonamide)
|
|
Sulfanilamide (5 g)
|
|
Sulfanilamide Melting Point Standard (1 g) (Approximately 165 degrees)
|
|
Sulfanilic Acid (200 mg) (4-Aminobenzenesulfonic acid)
|
|
Sulfapyridine (200 mg)
|
|
Sulfaquinoxaline (200 mg)
|
|
Sulfaquinoxaline Related Compound A (25 mg) (N1,N2-diquinoxalin-2-ylsulfanilamide)
|
|
Sulfasalazine (125 mg)
|
|
Sulfathiazole (350 mg)
|
|
スルフィンピラゾン
販売終了
|
|
Sulfisoxazole (200 mg)
|
|
Sulfisoxazole Acetyl (200 mg)
|
|
Sulindac (200 mg)
|
|
Sulindac Related Compound A (20 mg) ((E)-2-{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid)
|
|
Sulindac Related Compound B (20 mg) ((Z)-2-{5-fluoro-2-methyl-1-[4-(methylsulfonyl)benzylidene]-1H-inden-3-yl}acetic acid)
|
|
Sulindac Related Compound C (20 mg) ((Z)-2-{5-fluoro-2-methyl-1-[4-(methylthio)benzylidene]-1H-inden-3-yl}acetic acid)
|
|
Sulisobenzone (500 mg)
|
|
Sumatriptan (50 mg)
|
|
Sumatriptan Succinate (200 mg)
|
|
Sumatriptan Succinate Related Compound A (15 mg) ([3-[2-(Dimethylamino)ethyl]-2-[[3-[2-(dimethylamino) ethyl]-1H-indol-5-yl]methyl]-1H-indol-5-yl]-N-methylmethanesulfonamide succinate salt)
|
|
Sumatriptan Succinate Related Compound C (50 mg) ([3-[2-(dimethylamino)ethyl]-1-(hydroxymethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide succinate salt)
|
|
Sumatriptan Succinate Related Impurities (25 mg)
|
|
Sunflower Oil (1 g)
|
|
Suprofen (200 mg)
|
|
Silicified Microcrystalline Cellulose (1 g)
|
|